Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: SRI INTERNATIONAL
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2012-08-01 to 2018-12-31
Current total value of award: $10398294.68
Description: ANALYSIS OF ANTI-CANCER CHEMICALS & PHARMACEUTICAL FORMULATIONS